Maze Therapeutics, Inc. · NASDAQ:MAZE

Bernstein Harold sold 14,609 Maze Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Bernstein Harold (President, R&D & CMO) sold 14,609 Maze Therapeutics, Inc. shares at an average US$29.91 for US$437K under a trading plan, leaving 0 shares. Filed Jul 2, 2026 (Form 4).

Sold: 14,609 shares
Price: US$29.91 average (US$29.87 to US$30.34)
Value: US$437K
Holding after: 0 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President, R&D & CMO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jul 1, 2026	Common Stock	Option exercise	14,609	US$10.42	14,609	Direct
Jul 1, 2026	Common Stock	Sale	13,409	US$29.87	1,200	Direct
Jul 1, 2026	Common Stock	Sale	1,200	US$30.34	0	Direct

Source

View original at SEC

Related